Ivonescimab Injection clinical trials

Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients

This study looks at two different drug treatments for advanced non-small cell lung cancer. It compares a new drug called ivonescimab with a standard treatment, pembrolizumab, both given with chemotherapy. The aim is to see which treatment works better and is safer.